InternationalUSRemember you can easily switch between MIP US and MIP International at any time

In-house roundup: Pay for delay opposed by all; AI spurs pharma IP refocus; energy digitalisation pushes patent overhaul



Patrick Wingrove, London


Managing IP rounds up the latest news and analysis from patent-focused businesses

Money

Seminal pay for delay law opposed by pharma companies 

Generics and innovator companies say they don’t like the new and ‘badly-worded’ legislation introduced by California that bans drug settlements and could actually raise drug prices. Read more... 

AI alliances will push pharma refocus on patent bundles and licensing 

Pharma companies say AI’s potential to make R&D models more efficient and less expensive will drive the development of therapeutics that require different IP strategies. Read more... 

Energy digitalisation spurs industry IP overhaul 

SBM Offshore and IFP Energies explain how the energy sector has embraced digital technologies such as AI to drive efficiencies – and how that move is creating data rights and eligibility challenges. Read more... 




Comments






More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements